US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 1.205
  • +0.015+1.26%
Trading Nov 6 15:41 ET
435.60MMarket Cap-1544P/E (TTM)

About Lexicon Pharmaceuticals Company

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Company Profile

SymbolLXRX
Company NameLexicon Pharmaceuticals
Listing DateApr 7, 2000
Issue Price22.00
Founded1995
CEODr. Michael Exton, PhD
MarketNASDAQ
Employees285
Fiscal Year Ends12-31
Address2445 Technology Forest Boulevard,11th floor
CityThe Woodlands
ProvinceTexas
CountryUnited States of America
Zip Code77381-1160
Phone1-281-863-3000
Websitehttp://www.lexpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael Exton, PhD
  • Chief Executive Officer and Director
  • --
  • Dr. Craig B. Granowitz, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 1.53M
  • Thomas A. Garner
  • Senior Vice President and Chief Commercial Officer
  • --
  • Kristen L. Alexander
  • Principal Financial Officer, Vice President, Finance & Accounting and Principal Accounting Officer
  • --
  • Brian T. Crum
  • Senior Vice President and General Counsel
  • 1.42M
  • Dr. Kenneth B. Kassler-Taub, M.D.
  • Senior Vice President, Regulatory and Quality Assurance
  • --
  • Wendy E. McDermott
  • Vice President, Human Resources
  • --
  • Dr. Alan J. Main,PhD
  • Executive Vice President, Innovation and Chemical Sciences
  • 1.39M
  • Raymond Debbane
  • Non-Executive Chairman of the Board
  • 127.82K
  • Dr. Robert J. Lefkowitz,M.D.
  • Independent Director
  • 94.96K
  • Diane E. Sullivan
  • Independent Director
  • 176.42K
  • Dr. Judith L. Swain,M.D.
  • Independent Director
  • 104.96K
  • Philippe J. Amouyal
  • Independent Director
  • 100.52K
  • Christopher J. Sobecki
  • Independent Director
  • 89.96K
  • Dr. Samuel L. Barker,PhD
  • Independent Director
  • 117.46K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data